Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

NMR vs KB: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

KB Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 7–2 Matrix Metrics)

KB Overall Winner 6-Pillar Tally: NMR 1 – 4 KB (1 Tie) Matrix Metrics: NMR 2 – 7 KB

As of Nov 17, 2026, KB Financial Group Inc (KB) is the stronger overall head-to-head candidate over Nomura Holdings, Inc (NMR) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NMR carries a Unified Composite Score of 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin), whereas KB carries 54.3/100 (HOLD) at $115.77 (0.0x Forward P/E, 26.2% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NMR vs KB
NMR NYSE
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.74% 1D
Market Cap $28.3B
TTM Revenue $14.9B
Forward P/E 12.7x
Beta / 30D Vol 1.03β · 29% Vol
Unified Composite Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.5 · SMA20: $9.40 · SMA50: $9.68
KB NYSE Head-to-Head Winner
KB Financial Group Inc
Commercial Banks, Nec
$115.77
-1.65% 1D
Market Cap $40.8B
TTM Revenue $23.4B
Forward P/E 0.0x
Beta / 30D Vol 1.33β · 29% Vol
Unified Composite Score
54.3 / 100 HOLD
Tech 49.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 48
RSI-14: 48.2 · SMA20: $114.36 · SMA50: $120.71

6-Pillar Scorecard Institutional Category Breakdown (NMR 1 – 4 KB)

Columns: Metric · NMR · KB
1. Valuation Multiples KB
Forward P/E 12.7x 0.0x
Trailing P/E 11.2x 10.1x
PEG Ratio 0.81x 0.71x
EV / Revenue 1.9x 1.7x
2. Growth & Scale KB
Revenue Growth (YoY) +17.9% +514.4%
Earnings Growth (YoY) +13.6% +21.1%
TTM Revenue (USD) $14.9B $23.4B
Market Cap $28.3B $40.8B
3. Profitability & Quality KB
Gross Margin 77.4% 100.0%
Operating Margin 25.1% 26.2%
Net Profit Margin 17.1% 17.2%
Return on Equity (ROE) 11.5% 10.2%
4. Balance Sheet & Cash Flow NMR
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $8.17 Book/Sh · 11.5% ROE $30.20 Book/Sh · 10.2% ROE
Dividend Yield 3.34% 2.82%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 30.7% (<1st %ile) 27.1% (7th %ile)
Put/Call OI Skew Thin ADR Chain Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat KB
OpEx & R&D Intensity 52.3% of Rev ($7.77B) 73.8% of Rev ($17.3B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Capital Markets Operator Banks - Regional Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NMR (2) vs KB (7)
Institutional Metric NMR KB Criterion Row Edge
Market Capitalization
Scale
$28.3B $40.8B Larger Scale KB
Trailing P/E Ratio
Valuation
11.2x 10.1x Lower Multiple KB
Forward P/E Ratio
Valuation
12.7x 0.0x Lower Multiple KB
Revenue Growth (YoY)
Growth
+17.9% +514.4% Higher Growth KB
Operating Margin (TTM)
Profitability
25.1% 26.2% Higher Margin KB
Net Profit Margin
Profitability
17.1% 17.2% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
11.5% 10.2% Higher ROE NMR
52-Week Range Position
Momentum
60% ($7–$11) 66% ($81–$133) Stronger Trend KB
Beta / 30D Volatility
Risk Regime
1.03β · 29% Vol 1.33β · 29% Vol Lower Realized Risk NMR
Unified Institutional Score
Composite Signal
44.5 / 100 (HOLD) 54.3 / 100 (HOLD) Higher Composite KB
Trailing 12M Revenue (USD)
Operating Scale
$14.9B $23.4B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
77.4% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.81x PEG · 1.9x EV/Rev 0.71x PEG · 1.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($8.17 Book/Sh · 11.5% ROE) N/A ($30.20 Book/Sh · 10.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NMR +5.19 pp
NMR: +2.36% · KB: -2.83%
3M Horizon KB +1.61 pp
NMR: -1.84% · KB: -0.23%
6M Horizon NMR +4.37 pp
NMR: +16.69% · KB: +12.32%
1Y Horizon KB +3.71 pp
NMR: +26.32% · KB: +30.03%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs KB. Trailing 12-month operating profitability (NMR 25.1% vs KB 26.2%) and valuation multiples (NMR 12.7x vs KB 0.0x Forward P/E) are benchmarked directly in Pillar 4 below.

NMR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14.9B
Gross Margin77.4%
Op. Margin25.1%
ROE / Fwd P/E11.5% · 12.7x
KB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$23.4B
Gross Margin100.0%
Op. Margin26.2%
ROE / Fwd P/E10.2% · 0.0x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NMR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 30.7%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NMR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
KB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 27.1%
IV Percentile 7th %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NMR Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment 52.3% of Rev ($7.77B)
90D Engineering Disclosures 0 Published
KB Moat Profile Scale & Operating Efficiency Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $40.8B market capitalization and 26.2% operating margin.
OpEx & R&D Reinvestment 73.8% of Rev ($17.3B)
90D Engineering Disclosures 0 Published

Investor FAQ NMR vs KB Key Questions & Quantitative Answers

As of Nov 17, 2026, KB Financial Group Inc (KB) is the stronger overall head-to-head candidate over Nomura Holdings, Inc (NMR) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NMR carries a Unified Composite Score of 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin), whereas KB carries 54.3/100 (HOLD) at $115.77 (0.0x Forward P/E, 26.2% operating margin). Technically, NMR sits in a Neutral phase (RSI 45.5, UNCLASSIFIED options structure) and KB sits in a Neutral phase (RSI 48.2, UNCLASSIFIED options structure).

KB leads the Growth & Scale pillar: NMR posts +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin), compared with KB at +514.4% YoY revenue growth and +21.1% YoY earnings growth on $23.4B TTM revenue (100.0% gross margin, 26.2% operating margin). On trailing 12-month operating scale, NMR generates $14.9B in USD-normalized revenue versus $23.4B for KB. In operating R&D and SG&A reinvestment, NMR deploys 52.3% of Rev ($7.77B) (0 90-day corporate R&D disclosures) versus 73.8% of Rev ($17.3B) (0 disclosures) for KB.

KB screens cheaper on headline valuation multiples. NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin), whereas KB trades at 0.0x Forward P/E, 10.1x Trailing P/E, 0.71x PEG, and 1.7x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NMR (11.5% ROE) versus KB (10.2% ROE) capital efficiency.

In options market volatility and institutional positioning, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk). By comparison, KB carries 27.1% implied volatility (7th %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.33β · 29% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.